• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis.抗环瓜氨酸肽2抗体:这种血清学标志物对早期类风湿关节炎诊断能力的概述与展望
Clin Rev Allergy Immunol. 2008 Feb;34(1):36-9. doi: 10.1007/s12016-007-8029-y.
2
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.抗环瓜氨酸肽2(CCP2)自身抗体在预测早期未分化关节炎中的类风湿关节炎方面优于其他潜在的诊断生物标志物。
Clin Rheumatol. 2007 Oct;26(10):1627-33. doi: 10.1007/s10067-007-0558-5. Epub 2007 Feb 8.
3
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.抗环瓜氨酸化蛋白抗体在类风湿关节炎中的诊断及预测价值:一项系统文献综述
Ann Rheum Dis. 2006 Jul;65(7):845-51. doi: 10.1136/ard.2006.051391. Epub 2006 Apr 10.
4
A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis.类风湿关节炎首次和第二次抗环瓜氨酸肽(CCP1和CCP2)自身抗体检测的诊断准确性和预后价值比较
Ann Rheum Dis. 2005 Oct;64(10):1510-2. doi: 10.1136/ard.2004.035089. Epub 2005 Mar 30.
5
Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.抗环瓜氨酸肽2(Anti-CCP2)在类风湿关节炎诊断中是类风湿因子的辅助指标而非替代指标:抗CCP2抗体在埃及类风湿关节炎患者中的诊断效用
Scand J Rheumatol. 2008 Sep-Oct;37(5):329-36. doi: 10.1080/03009740802116208.
6
Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.第二代抗环瓜氨酸肽(抗CCP2)抗体可替代其他抗丝聚蛋白抗体并改善类风湿性关节炎的诊断。
Scand J Rheumatol. 2004;33(4):218-20. doi: 10.1080/03009740410005403.
7
Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.酶联免疫吸附测定法检测抗突变型瓜氨酸波形蛋白在类风湿关节炎中的临床评估
J Rheumatol. 2007 Aug;34(8):1658-63. Epub 2007 Jul 1.
8
Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.类风湿关节炎中的抗环瓜氨酸肽抗体亚型:与疾病持续时间、类风湿因子产生及共同表位存在的关联
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):253-60.
9
Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.在苏丹类风湿关节炎患者中,抗 CCP2 和 RF 同种型的出现及其与年龄和疾病严重程度的关系。
Clin Rheumatol. 2019 Jun;38(6):1545-1553. doi: 10.1007/s10067-019-04431-6. Epub 2019 Jan 17.
10
The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis--a systematic review.类风湿关节炎中第二代抗环瓜氨酸肽抗体(抗CCP2)检测的应用——一项系统评价
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S69-76.

引用本文的文献

1
Precision Medicine in Rheumatology: The Role of Biomarkers in Diagnosis and Treatment Optimization.风湿病学中的精准医学:生物标志物在诊断和治疗优化中的作用
J Clin Med. 2025 Mar 4;14(5):1735. doi: 10.3390/jcm14051735.
2
Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.基于具有三种翻译后修饰(瓜氨酸化、同型瓜氨酸化和乙酰化)的烯醇化酶肽抗原(CEP-1)的新型嵌合肽,用于确定类风湿关节炎的诊断和严重程度。
Int J Mol Sci. 2024 Oct 3;25(19):10654. doi: 10.3390/ijms251910654.
3
Effect of Antigen Valency on Autoreactive B-Cell Targeting.抗原价态对自身反应性B细胞靶向的影响。
Mol Pharm. 2024 Feb 5;21(2):481-490. doi: 10.1021/acs.molpharmaceut.3c00527. Epub 2023 Oct 20.
4
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis.抗瓜氨酸化肽抗体表位扩展和 HLA DRB1“共享表位”在阳性检查点抑制剂诱导的炎症性关节炎中比在长期类风湿关节炎中更为少见。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003012.
5
Comparison of different assays for the detection of anticyclic citrullinated peptide antibodies in patients with rheumatoid arthritis.比较不同检测方法在类风湿关节炎患者中抗环瓜氨酸肽抗体的检测。
Front Immunol. 2022 Aug 2;13:940713. doi: 10.3389/fimmu.2022.940713. eCollection 2022.
6
Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab.甲氨蝶呤或托珠单抗治疗的早期类风湿关节炎患者的全面探索性自身抗体分析。
PLoS One. 2020 Dec 10;15(12):e0241189. doi: 10.1371/journal.pone.0241189. eCollection 2020.
7
Insights of rheumatoid arthritis risk factors and associations.类风湿关节炎风险因素及关联的见解。
J Transl Autoimmun. 2019 Aug 20;2:100012. doi: 10.1016/j.jtauto.2019.100012. eCollection 2019 Dec.
8
Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis.抗合成瓜氨酸化肽表位抗体与类风湿关节炎的疾病活动和发作相关。
PLoS One. 2020 Apr 23;15(4):e0232010. doi: 10.1371/journal.pone.0232010. eCollection 2020.
9
An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders.瓜氨酸化在自身免疫性疾病中的固有作用概述。
J Immunol Res. 2019 Nov 25;2019:7592851. doi: 10.1155/2019/7592851. eCollection 2019.
10
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype.血清学表型定义的类风湿关节炎亚类的不同 HLA 相关性。
Am J Hum Genet. 2019 Sep 5;105(3):616-624. doi: 10.1016/j.ajhg.2019.08.002. Epub 2019 Aug 29.

本文引用的文献

1
Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.用于类风湿关节炎诊断的6种瓜氨酸化蛋白/肽抗体检测方法的技术与诊断性能
Clin Chem. 2007 Mar;53(3):498-504. doi: 10.1373/clinchem.2006.078063. Epub 2007 Jan 26.
2
Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.抗环瓜氨酸肽抗体在未分化关节炎和类风湿关节炎中的同种型分布反映了持续的免疫反应。
Arthritis Rheum. 2006 Dec;54(12):3799-808. doi: 10.1002/art.22279.
3
Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.(早期)类风湿关节炎中瓜氨酸化抗原的自身抗体
Autoimmun Rev. 2006 Nov;6(1):37-41. doi: 10.1016/j.autrev.2006.03.008. Epub 2006 Apr 19.
4
Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!类风湿关节炎中的瓜氨酸化蛋白:至关重要……但还不够!
Arthritis Rheum. 2006 Nov;54(11):3381-9. doi: 10.1002/art.22206.
5
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?非类风湿性关节炎疾病样本中抗环瓜氨酸肽阳性:是否依赖瓜氨酸?
Ann Rheum Dis. 2007 Apr;66(4):511-6. doi: 10.1136/ard.2006.058933. Epub 2006 Sep 19.
6
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.抗环瓜氨酸肽抗体对极早期类风湿关节炎的诊断效用
J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.
7
Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.类风湿关节炎中的抗环瓜氨酸肽抗体:与疾病侵袭性的关系
Clin Exp Rheumatol. 2006 May-Jun;24(3):281-6.
8
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.抗瓜氨酸化波形蛋白抗体在类风湿关节炎中的诊断价值
Arthritis Res Ther. 2006;8(4):R119. doi: 10.1186/ar2008.
9
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.抗人瓜氨酸化纤维蛋白原酶联免疫吸附测定的诊断价值及与其他四种抗瓜氨酸化蛋白检测方法的比较
Arthritis Res Ther. 2006;8(4):R122. doi: 10.1186/ar2011.
10
Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.类风湿关节炎中的自身抗体:与已确诊类风湿关节炎疾病严重程度的关联
Clin Rheumatol. 2007 Feb;26(2):201-4. doi: 10.1007/s10067-006-0275-5. Epub 2006 Mar 30.

抗环瓜氨酸肽2抗体:这种血清学标志物对早期类风湿关节炎诊断能力的概述与展望

Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis.

作者信息

van Venrooij Walther J, Zendman Albert J W

机构信息

Department of Biomolecular Chemistry, Radboud University Nijmegen, Nijmegen, The Netherlands.

出版信息

Clin Rev Allergy Immunol. 2008 Feb;34(1):36-9. doi: 10.1007/s12016-007-8029-y.

DOI:10.1007/s12016-007-8029-y
PMID:18270856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2243253/
Abstract

The literature of the last 4 years confirms that the anti-CCP2 test is a very useful marker for the early and specific diagnosis of rheumatoid arthritis (RA). The anti-CCP2 test is very specific for RA (95-99%) and has sensitivity comparable to that of the rheumatoid factor (70-75%). The antibodies can be detected very early in the disease and can be used as an indicator for the progression and prognosis of RA. In this review, these interesting properties and some future possibilities of this diagnostic test are discussed.

摘要

过去4年的文献证实,抗环瓜氨酸肽2(anti-CCP2)检测是类风湿关节炎(RA)早期特异性诊断的一项非常有用的标志物。抗CCP2检测对RA具有高度特异性(95-99%),其敏感性与类风湿因子相当(70-75%)。这些抗体在疾病早期即可检测到,并可作为RA病情进展和预后的指标。在本综述中,将讨论这项诊断检测的这些有趣特性以及一些未来的可能性。